Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting ...

San Francisco-based Trace Neuroscience has launched with $101 million in series A funding to develop ALS therapies focused on ...

Ten years after her sexual assault, she discovered that the evidence in her rape kit hadn’t been tested — and neither had ...

Among the various forms of MND, amyotrophic lateral sclerosis (ALS) is most prevalent in the UK, impacting around 5,000 ...

The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the CIC vaccine ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

The condition is a rapidly progressive neurodegenerative disorder leading to wasting, paralysis and eventual death from ...

Amyotrophic lateral sclerosis (ALS) is the most common form of MND and there is currently no cure for the condition which ...

Friends and family gathered on Friday night to bid farewell to community leader and nature promoter Omar Gallardo with an ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...